Filing Details
Mereo BioPharma Group plc (NASDAQ:MREO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MREO
Mereo BioPharma Group plc (MREO) Files Quarterly Report for Q0
Mereo BioPharma Group plc (NASDAQ:MREO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Mereo BioPharma Group plc (NASDAQ:MREO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Mereo BioPharma Group plc filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $0.31 per share with a market capitalization of $360.8 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Mereo BioPharma Group plc's stock currently trades at $0.31 with a market capitalization of $360.8M.
The 10-Q provides Mereo BioPharma Group plc's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Mereo BioPharma Group plc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MREO Stock Page
Frequently Asked Questions
Where can I read MREO's SEC filings?
Browse all filings on our MREO SEC filings page.
What types of SEC filings does Mereo BioPharma Group plc file?
Public companies like Mereo BioPharma Group plc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.